Skip to content

Study on the Clinical Mechanism of Acupuncture Treatment of diabetes Peripheral Neuropathy Based on Lipid Metabolomics

Study on the Clinical Mechanism of Acupuncture Treatment of diabetes Peripheral Neuropathy Based on Lipid Metabolomics

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073046
Enrollment
Unknown
Registered
2023-06-30
Start date
2023-07-15
Completion date
Unknown
Last updated
2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic peripheral neuropathy

Interventions

control group:basic treatment
treatment group:acupuncture+basic treatment
Blank group:None

Sponsors

Jiangsu Province Official Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 70 Years

Inclusion criteria

Inclusion criteria: ? Meet the clinical diagnostic criteria of DPN in this study; ? Age: 35~70 years old; ? Vital signs are stable, blood pressure, heart rate and other indicators are normal; ? Normal cognitive ability and expression ability, no serious cardio-cerebrovascular disease; ? Volunteer to participate in the study and sign the informed consent form, and can cooperate with doctors to complete the clinical study.

Exclusion criteria

Exclusion criteria: ? Those who are sensitive to acupuncture and moxibustion and have needle sickness; ? Women who are preparing to be pregnant or in pregnancy, nursing women, and women who take contraceptives for a long time; ? Severe complications of diabetes, or combined with hyperthyroidism and other diseases affecting blood sugar; ? Patients with neuropathy caused by other factors or complicated with intervertebral disc disease, spinal nerve root disease and other diseases; ? Those who have serious primary diseases or suffer from serious diseases such as malignant tumors, serious genetic diseases and infectious diseases; Note: Anyone with any of the above conditions shall not participate in this study

Design outcomes

Primary

MeasureTime frame
Lipid metabolites;

Secondary

MeasureTime frame
electromyogram;TCSS;

Countries

China

Contacts

Public ContactMing Wang

Jiangsu Province Official Hospital

lianxiaoyang6666@163.com+86 188 0515 5633

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026